Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00009906
Recruitment Status : Terminated
First Posted : February 3, 2004
Last Update Posted : December 23, 2014
Eastern Cooperative Oncology Group
Southwest Oncology Group
NCIC Clinical Trials Group
Information provided by (Responsible Party):
National Cancer Institute (NCI)